Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Encore Capital Group Announces Second Quarter 2025 Financial Results
-
The Honest Company Reports Second Quarter 2025 Results
-
Amplify Energy Announces Strategic Initiatives Update, Second Quarter 2025 Results, and Updated Full-Year 2025 Guidance
-
Remitly Reports Second Quarter 2025 Results Above Outlook and Raises Full Year 2025 Outlook
-
Snail, Inc. Sets Second Quarter 2025 Conference Call for Wednesday, August 13, 2025 at 4:30 p.m. ET
-
MaxCyte Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
-
LiveRamp Announces Results for First Quarter FY26
-
Assembly Biosciences Reports Interim Phase 1a Data from Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus
-
HilleVax Reports Second Quarter 2025 Financial Results
-
Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
-
Senseonics Holdings, Inc. Reports Second Quarter Financial Results
-
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
-
Crane NXT Reports Second Quarter 2025 Results
-
Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements
-
Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference
-
BBSI Reports Strong Second Quarter 2025 Financial Results
-
red violet Announces Second Quarter 2025 Financial Results
-
Artiva Biotherapeutics Reports Second Quarter 2025 Financial Results, Recent Business Highlights
-
Veeco Reports Second Quarter 2025 Financial Results
-
Latham Group, Inc. to Participate at Upcoming Conferences in August 2025
-
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
-
Upwork Reports Second Quarter 2025 Financial Results
-
Revolution Medicines Reports Second Quarter 2025 Financial Results and Update on Corporate Progress
-
Green Thumb Industries Reports Second Quarter 2025 Results
-
Outset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and Utilization
-
Bowman Reports Record Second Quarter 2025 Results
-
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Voyager Reports Second Quarter 2025 Financial and Operating Results
-
Keros Therapeutics Reports Second Quarter 2025 Financial Results
-
Adverum Biotechnologies to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
-
Soleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports Second Quarter 2025 Financial Results
-
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
-
Duolingo Doubles Down on Delight with Acquisition of Music Gaming Startup NextBeat’s Innovative Team
-
Sunrun Reports Second Quarter 2025 Financial Results
-
Usio Announces Second Quarter 2025 Financial Results
-
Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Duolingo Reports 41% Revenue Growth, 46% Subscription Revenue Growth and Record Profitability in Second Quarter 2025; Raises Full-Year Guidance
-
Howard Hughes Holdings Inc. Reports Second Quarter 2025 Results
-
Capital Southwest Announces Financial Results for First Fiscal Quarter Ended June 30, 2025
-
Clearfield Reports Third Quarter Fiscal 2025 Results
-
Symbotic Reports Third Quarter Fiscal Year 2025 Results
-
Arcutis Announces Second Quarter 2025 Financial Results and Provides Business Update
-
Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
-
Fredonia Mining Inc. Grants Stock Options
-
Judicial Review Petition Dismissed, Mount Polley to Continue Constructing TSF Raise
-
Missouri Scholarship & Loan Foundation and MOHELA Launch the EmpowerED Internship Program
-
TCM Group A/S revise full year guidance for 2025
-
TCM Group A/S to acquire remaining 55% of shares in Celebert ApS
-
Wearable Devices Ltd. Announces a Warrant Inducement Transaction for $2.4 Million in Gross Proceeds
